title: Evaluation of community contribution to tuberculosis control in Cape Town, South Africa.
abstract: METHODS
  Low income, high density, urban settlements in Cape Town, South Africa.
  
  
  OBJECTIVE
  To evaluate community treatment supervision as part of tuberculosis (TB) programme implementation.
  
  
  METHODS
  A non-randomised prospective study was conducted under programme conditions from January 1998 to December 1999, comparing TB programme performance in an area with (Guguletu), and an area without (Nyanga) the option of TB treatment supervision by community health workers.
  
  
  RESULTS
  Data were collected for 2873 adult TB patients. For smear-positive TB patients, treatment cure rates were higher in the intervention area (Guguletu) than in the control area (Nyanga) (58% vs. 50%, P = 0.0378) and for retreatment cases (47% vs. 35%, P = 0.0791), treatment success rates were similar.
  
  
  CONCLUSIONS
  Community health worker support contributed to better TB control programme performance than an approach based exclusively on health facilities. Clear government policy and support for lay health worker programmes in TB control is needed.
authors.affiliation: Health Systems Trust, Riverside Centre, Cape Town, South Africa. liliand@hst.org.za
authors.forename: L
authors.initials: L
authors.lastname: Dudley
authors.forename: V
authors.initials: V
authors.lastname: Azevedo
authors.forename: R
authors.initials: R
authors.lastname: Grant
authors.forename: J H
authors.initials: JH
authors.lastname: Schoeman
authors.forename: L
authors.initials: L
authors.lastname: Dikweni
authors.forename: D
authors.initials: D
authors.lastname: Maher
mesh_terms: D000293:Adolescent; D000328:Adult; D003153:Community Health Services / Q000706:statistics & numerical data; D003150:Community Health Workers; D005260:Female; D006291:Health Policy; D006801:Humans; D008297:Male; D015397:Program Evaluation; D011446:Prospective Studies; D013019:South Africa; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*